| dc.creator |
Altindag, Rojhad |
|
| dc.creator |
Kilicaslan, Baris |
|
| dc.creator |
Yildirim, Tarik |
|
| dc.creator |
Aktas, Zihni |
|
| dc.creator |
KARABACAK, Mustafa |
|
| dc.creator |
Oz, Ahmet |
|
| dc.creator |
MURAT, SELDA |
|
| dc.creator |
Arik, Baran |
|
| dc.creator |
Gul, Sefa |
|
| dc.creator |
Ergene, Asim Oktay |
|
| dc.creator |
Kiris, Tuncay |
|
| dc.creator |
AVCI, EYÜP |
|
| dc.creator |
Ekin, Tuba |
|
| dc.creator |
Akgun, Didar Elif |
|
| dc.creator |
Tiryaki, Mucahit |
|
| dc.creator |
Yidirim, Arafat |
|
| dc.creator |
Hazir, Kutluhan |
|
| dc.creator |
Murat, Bektas |
|
| dc.creator |
Yeni, Mehtap |
|
| dc.creator |
Guzel, Tuncay |
|
| dc.date |
2022-02-01T00:00:00Z |
|
| dc.identifier |
229ab696-3f42-4699-9c2f-c8871ea6db45 |
|
| dc.identifier |
10.1007/s11239-021-02487-3 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/229ab696-3f42-4699-9c2f-c8871ea6db45/oai |
|
| dc.description |
Objective We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey. Methods This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st-May 15st, 2020; n = 733) or pre- COVID-19 era group (March 11st-May 15st, 2019; n = 1055). Also, the patients in COVID-19 era were grouped as COVID-19 positive (n = 65) or negative (n = 668). Results There was a 30.5% drop in STEMI admission during COVID-19 era in comparison to pre-COVID-19 era. The patients admitted to the medical centers during COVID-19 era had a longer symptom-to-first medical contact time [120 (75-240) vs. 100 (60-180) minutes, p < 0.001]. COVID-19 positive STEMI patients had higher thrombus grade and lower left ventricular ejection fraction compared to COVID-19 negative patients. COVID-19 positive patients had higher mortality (28% vs. 6%, p < 0.001) and cardiogenic shock (20% vs. 7%, p < 0.001) rates compared with those without COVID-19. Matching based on propensity scores showed higher mortality and high thrombus grade in STEMI patients who were infected by SARS-COV-2 (each p < 0.05). Conclusions We detected significantly lower STEMI hospitalization rates and significant delay in duration of symptom onset to first medical contact in the context of Turkey during the COVID-19 outbreak. Moreover, high thrombus grade and mortality were more common in COVID-19 positive STEMI patients. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry) |
|
| dc.type |
info:eu-repo/semantics/article |
|